845 related articles for article (PubMed ID: 9494858)
1. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
4. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
Shimada T; Yamagata M; Hiraishi H
Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
[TBL] [Abstract][Full Text] [Related]
5. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
8. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
10. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
[TBL] [Abstract][Full Text] [Related]
11. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
[TBL] [Abstract][Full Text] [Related]
12. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
McCarthy DM
Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
[TBL] [Abstract][Full Text] [Related]
16. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
17. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
19. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
Jost C; Marbet UA
Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
[TBL] [Abstract][Full Text] [Related]
20. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
